| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.05 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |